EUVIMEDEUVIMED entdecken
Open Access

Acid‐Triggered, Enzyme‐Enabled EPS‐Degrading Nanoplatform With Enhanced In Situ Retention for Intravenous Biofilm Therapy

Bo Liu, Cheng Wang, Liang Tian, Ruyue Li, Shuyi Lv, Zhencheng Sun, Minghui Xiao, Qinyang Zheng, Linqi Shi, Chunlei Zhu iD

Advanced Materials · 2026-07 · 38 (42)

DOI: 10.1002/adma.73749 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 18.06.2026. Verfasst von Bo Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Functional Polymer Materials of Ministry of Education, State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center…. Hauptthemen laut MEDLINE: Biofilms, Anti-Bacterial Agents, Extracellular Polymeric Substance Matrix, Nanoparticles. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key R&D Program of China, Natural Science Foundation of Tianjin, Beijing National Laboratory for Molecular Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial biofilms present a major challenge to antibacterial therapy due to their dense extracellular polymeric substance (EPS) matrix, which limits nanoparticle penetration and reduces drug efficacy. Here, we report a pH‐responsive, surface charge‐adaptive multifunctional nanosystem (DA‐L@DTTB/Bro) for efficient in vivo treatment of biofilm‐associated infections. The nanosystem integrates pH‐triggered charge adaptation, in situ self‐aggregation, photothermal responsiveness, enzymatic EPS degradation, and NIR‐II imaging. Cationic phospholipid AGPDP, together with cholesterol and thermosensitive DPPC, self‐assembled into liposomes encapsulating bromelain in the hydrophilic core and an NIR‐II‐emissive photothermal agent (DTTB) in the hydrophobic layer. Surface modification with DA‐functionalized chitosan (CS‐DA) generates negatively charged nanoparticles for prolonged circulation. At acidic infection sites, DA hydrolysis restores the cationic surface, enhancing biofilm penetration, while residual CS‐DA induces self‐aggregation to improve retention. NIR irradiation triggers DTTB‐mediated hyperthermia, directly killing bacteria and disassembling liposomes to release bromelain, which degrades EPSs and facilitates biofilm dispersion. The nanosystem eradicates methicillin‐resistant Staphylococcus aureus biofilms in vitro with 99.99% efficiency, enables high‐contrast NIR‐II imaging, persists at abscess sites in vivo, and accelerates wound healing. Furthermore, it demonstrates effective therapeutic activity against biofilm‐associated infections in deep pulmonary tissues. This study presents a versatile intravenous strategy for targeted, synergistic therapy against biofilm‐associated infections in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsAnti-Bacterial AgentsExtracellular Polymeric Substance MatrixNanoparticlesHydrogen-Ion ConcentrationAnimalsMethicillin-Resistant Staphylococcus aureusLiposomesChitosanInfrared RaysMice

Stichwörter der Autor:innen

NIR‐II imaging and synergistic treatmentbiofilm penetration and retentionbiofilm‐associated infectionenzyme‐mediated EPS degradationpH‐responsive nanoplatform

Substanzen

Anti-Bacterial AgentsLiposomesChitosan

Autor:innen und Institutionen

  • Key Laboratory of Functional Polymer Materials of Ministry of Education, State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center For New Organic Matter, College of Chemistry, Nankai University, Tian…
  • Beijing National Laboratory for Molecular Sciences, Beijing, China.

ORCID-Profile: Chunlei Zhu

Förderung

  • National Key R&D Program of China
  • Natural Science Foundation of Tianjin
  • Beijing National Laboratory for Molecular Sciences
  • Fundamental Research Funds for the Central Universities
  • National Key Research and Development Program of China
  • Natural Science Foundation of Tianjin Municipality

Zitieren

APA

Liu, B., Wang, C., Tian, L., Li, R., Lv, S., Sun, Z., Xiao, M., Zheng, Q., Shi, L., & Zhu, C. (2026). Acid‐Triggered, Enzyme‐Enabled EPS‐Degrading Nanoplatform With Enhanced In Situ Retention for Intravenous Biofilm Therapy. Advanced Materials, 38(42). https://doi.org/10.1002/adma.73749

Vancouver

Liu B, Wang C, Tian L, Li R, Lv S, Sun Z, et al. Acid‐Triggered, Enzyme‐Enabled EPS‐Degrading Nanoplatform With Enhanced In Situ Retention for Intravenous Biofilm Therapy. Advanced Materials. 2026;38(42). doi:10.1002/adma.73749

BibTeX
@article{Liu2026,
  author = {Liu, Bo and Wang, Cheng and Tian, Liang and Li, Ruyue and Lv, Shuyi and Sun, Zhencheng and Xiao, Minghui and Zheng, Qinyang and Shi, Linqi and Zhu, Chunlei},
  title = {Acid‐Triggered, Enzyme‐Enabled EPS‐Degrading Nanoplatform With Enhanced In Situ Retention for Intravenous Biofilm Therapy},
  journal = {Advanced Materials},
  year = {2026},
  volume = {38},
  number = {42},
  doi = {10.1002/adma.73749}
}
Kostenlos starten →